Tudóstér: Tóth Gábor publikációi

PDF
-
szűkítés
feltöltött közlemény: 11 Open Access: 9
2024
  1. Katona, T., Tóth, G., Petró, M., Harangi, B.: Advanced Multi-Label Image Classification Techniques Using Ensemble Methods.
    Mach. Learn. Knowl. Extr. 6 (2), 1281-1297, 2024.
    Folyóirat-mutatók:
    Q2 Artificial Intelligence (2023)
    Q1 Engineering (miscellaneous) (2023)
  2. Hevessy, Z., Tóth, G., Antal-Szalmás, P., Tőkés-Füzesi, M., Kappelmayer, J., Kárai, B., Ajzner, É., Working Group on Guidelines, Algorithms of the Hungarian Society of Laboratory Medicine: Algorithm of differential diagnosis of anemia involving laboratory medicine specialists to advance diagnostic excellence.
    Clin. Chem. Lab. Med. 62 (3), 410-420, 2024.
    Folyóirat-mutatók:
    Q1 Biochemistry (medical) (2023)
    Q1 Clinical Biochemistry (2023)
    Q1 Medicine (miscellaneous) (2023)
  3. Katona, T., Tóth, G., Petró, M., Harangi, B.: Developing New Fully Connected Layers for Convolutional Neural Networks with Hyperparameter Optimization for Improved Multi-Label Image Classification.
    Mathematics. 12 (6), 1-16, 2024.
    Folyóirat-mutatók:
    Q2 Computer Science (miscellaneous) (2023)
    Q2 Engineering (miscellaneous) (2023)
    Q2 Mathematics (miscellaneous) (2023)
2023
  1. Sebestyén, E., Major, N., Bodoki, L., Makai, A., Balogh, I., Tóth, G., Orosz, Z., Árkosy, P., Vaskó, A., Hódosi, K., Szekanecz, Z., Szekanecz, É., Hungarian OncoRheumatology Network (HORN) initiative: Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience.
    Front Oncol. 13 1-9, 2023.
    Folyóirat-mutatók:
    Q2 Cancer Research
    Q2 Oncology
  2. Fazekas, L., Szabó, B., Szegeczki, V., Fillér, C., Varga, Á., Godó, Z., Tóth, G., Reglődi, D., Juhász, T., Németh, N.: Impact Assessment of Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Hemostatic Sponge on Vascular Anastomosis Regeneration in Rats.
    Int. J. Mol. Sci. 24 1-24, 2023.
    Folyóirat-mutatók:
    Q2 Catalysis
    Q1 Computer Science Applications
    D1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    D1 Organic Chemistry
    Q1 Physical and Theoretical Chemistry
    D1 Spectroscopy
2020
  1. Tóth, G., Szöllősi, J., Abken, H., Vereb, G., Szöőr, Á.: A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts.
    Int. J. Mol. Sci. 21 (3), 1-11, 2020.
    Folyóirat-mutatók:
    Q2 Catalysis
    D1 Computer Science Applications
    D1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    D1 Organic Chemistry
    D1 Physical and Theoretical Chemistry
    D1 Spectroscopy
  2. Szöőr, Á., Tóth, G., Zsebik, B., Szabó, V., Eshhar, Z., Abken, H., Vereb, G.: Trastuzumab Derived HER2-specific CARs for the Treatment of Trastuzumab-Resistant Breast Cancer: CAR T Cells Penetrate and Eradicate Tumors That Are Not Accessible to Antibodies.
    Cancer Lett. 484 1-8, 2020.
    Folyóirat-mutatók:
    Q1 Cancer Research
    Q1 Oncology
2017
  1. Tóth, G., Szöllősi, J., Vereb, G.: Quantitating ADCC against adherent cells: impedance-based detection is superior to release, membrane permeability, or caspase activation assays in resolving antibody dose response.
    Cytom. Part A. 91 (10), 1021-1029, 2017.
    Folyóirat-mutatók:
    Q2 Cell Biology
    Q1 Histology
    Q1 Pathology and Forensic Medicine
2016
  1. Szöőr, Á., Ujlaky-Nagy, L., Tóth, G., Szöllősi, J., Vereb, G.: Cell confluence induces switching from proliferation to migratory signaling by site-selective phosphorylation of PDGF receptors on lipid raft platforms.
    Cell. Signal. 28 (2), 81-93, 2016.
    Folyóirat-mutatók:
    Q2 Cell Biology
  2. Tóth, G., Szöőr, Á., Simon, L., Yarden, Y., Szöllősi, J., Vereb, G.: The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity.
    mAbs. 8 (7), 1361-1370, 2016.
    Folyóirat-mutatók:
    Q2 Immunology
    Q1 Immunology and Allergy
2013
  1. Roszik, J., Tóth, G., Szöllősi, J., Vereb, G.: Validating pharmacological disruption of protein-protein interactions by acceptor photobleaching FRET imaging.
    In: Target Identification and Validation in Drug Discovery. Eds.: Jürgen Moll, Riccardo Colombo, Humana Press, Totowa, NJ, 165-78, 2013. ISBN: 9781627033107
feltöltött közlemény: 11 Open Access: 9
https://tudoster.idea.unideb.hu
A szolgáltatást nyújtja: DEENK